📰 Pharma Price News
Pharma Price News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Pharma Price. Real-time updates on events, politics, business and more.
October 19, 2023
PLx Pharma Inc. (NASDAQ:PLXP – Get Free Report)’s share price crossed above its fifty day moving average during trading on Monday . The stock has a fifty day moving average of $0.00 and traded as high as $0.00. PLx Pharma shares last traded at $0.00, with a volume of 3,000 shares. PLx Pharma Price Performance […]
July 19, 2023
Shares of ABVC BioPharma, Inc. (OTCMKTS:ABVC – Get Free Report) traded up 10% during mid-day trading on Tuesday . The company traded as high as $0.44 and last traded at $0.42. 410,710 shares were traded during trading, an increase of 0% from the average session volume of 409,231 shares. The stock had previously closed at […]
July 17, 2023
StockNews.com started coverage on shares of CTI BioPharma (NASDAQ:CTIC – Free Report) in a research note published on Friday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Other analysts also recently issued research reports about the stock. TD Cowen reduced their target price on shares of CTI BioPharma from $10.00 to $8.00 […]
July 16, 2023
Research analysts at StockNews.com began coverage on shares of CTI BioPharma (NASDAQ:CTIC – Get Free Report) in a research report issued on Friday. The firm set a “hold” rating on the biopharmaceutical company’s stock. Other research analysts have also issued reports about the company. TD Cowen lowered their price objective on CTI BioPharma from $10.00 […]
July 8, 2023
StockNews.com assumed coverage on shares of CTI BioPharma (NASDAQ:CTIC – Free Report) in a research report report published on Thursday. The firm issued a hold rating on the biopharmaceutical company’s stock. CTIC has been the topic of a number of other research reports. Stifel Nicolaus cut CTI BioPharma from a buy rating to a hold […]
June 28, 2023
StockNews.com started coverage on shares of CTI BioPharma (NASDAQ:CTIC – Get Rating) in a research note released on Tuesday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. A number of other equities analysts have also recently commented on CTIC. Stifel Nicolaus cut shares of CTI BioPharma from a buy rating to […]
June 22, 2023
StockNews.com assumed coverage on shares of CTI BioPharma (NASDAQ:CTIC – Get Rating) in a research report sent to investors on Monday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. A number of other brokerages also recently issued reports on CTIC. JMP Securities downgraded CTI BioPharma from an outperform rating to a […]
June 21, 2023
Shares of CTI BioPharma Corp. (NASDAQ:CTIC – Get Rating) hit a new 52-week high on Wednesday . The stock traded as high as $9.10 and last traded at $9.09, with a volume of 889761 shares traded. The stock had previously closed at $9.07. Analyst Ratings Changes CTIC has been the subject of several recent analyst […]
June 16, 2023
CTI BioPharma Corp. (NASDAQ:CTIC – Get Rating) was the target of a large increase in short interest in May. As of May 31st, there was short interest totalling 11,270,000 shares, an increase of 39.5% from the May 15th total of 8,080,000 shares. Based on an average trading volume of 5,510,000 shares, the short-interest ratio is […]
June 14, 2023
StockNews.com initiated coverage on shares of CTI BioPharma (NASDAQ:CTIC – Get Rating) in a research report sent to investors on Sunday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Several other research analysts have also recently weighed in on CTIC. Lake Street Capital cut shares of CTI BioPharma from a buy […]